Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events

作者: David Feinbloom , Kenneth A. Bauer

DOI: 10.1161/01.ATV.0000181762.31694.DA

关键词:

摘要: Arterial thrombosis results from endovascular injury and, to a lesser extent, alterations in hemostatic equilibrium. Although multiple hereditary and acquired risk factors have been described the pathophysiology of venous thrombosis, degree type abnormalities that contribute arterial are less well understood. Endothelial cell with elaboration proinflammatory mediators stimulates process thrombosis. this is most often result attributable atherosclerotic disease, other disease states can elicit similar response as well. Similarly, once has initiated, variations activity coagulation proteins endogenous anticoagulants, kinetics platelet aggregation, may alter effectiveness thrombus formation. Epidemiological studies identified several or inherited endothelial damage altered equilibrium, thereby predisposing patients These include hyperhomocysteinemia, elevated C-reactive protein, antiphospholipid antibodies, fibrinogen, Factor VII, plasminogen activator inhibitor-1 (PAI-1), thrombophilias, hyper-reactivity. This review explores our present understanding these development thrombotic events. At present, literature supports role for fibrinogen suggests lupus anticoagulants titers cardiolipin IgG antibodies predispose vascular In certain subsets patients, including those concomitant cardiac factors, <55 years age, women, thrombophilias such carriership factor V Leiden prothrombin G20210A mutations confer higher However, data on PAI-1, receptor polymorphisms contradictory lacking.

参考文章(122)
Augusto Di Castelnuovo, Giovanni de Gaetano, Maria Benedetta Donati, Licia Iacoviello, Platelet Glycoprotein Receptor IIIa Polymorphism PlA1 /PlA2 and Coronary Risk: a Meta-Analysis Thrombosis and Haemostasis. ,vol. 85, pp. 626- 633 ,(2001) , 10.1055/S-0037-1615644
K S Mccully, Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. American Journal of Pathology. ,vol. 56, pp. 111- 128 ,(1969)
Leonelo E Bautista, Iván A Arenas, Anderson Peñuela, Luz X Martı́nez, Total plasma homocysteine level and risk of cardiovascular disease: A meta-analysis of prospective cohort studies Journal of Clinical Epidemiology. ,vol. 55, pp. 882- 887 ,(2002) , 10.1016/S0895-4356(02)00434-1
D. Ardissino, P.M. Mannucci, P.A. Merlini, F. Duca, R. Fetiveau, L. Tagliabue, M. Tubaro, M. Galvani, F. Ottani, M. Ferrario, J. Corral, M. Margaglione, Prothrombotic Genetic Risk Factors in Young Survivors of Myocardial Infarction Blood. ,vol. 94, pp. 46- 51 ,(1999) , 10.1182/BLOOD.V94.1.46.413A27_46_51
Shigetaka Shimodaira, Fumihiro Ishida, Kiyoshi Kitano, Toshiro Ito, Polymorphisms of platelet membrane glycoprotein Ib alpha and plasma von Willebrand factor antigen in coronary artery disease. International Journal of Hematology. ,vol. 70, pp. 47- 51 ,(1999)
S. Santoso, T.J. Kunicki, H. Kroll, W. Haberbosch, A. Gardemann, Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood. ,vol. 93, pp. 2449- 2453 ,(1999) , 10.1182/BLOOD.V93.8.2449
F.R. Rosendaal, D.S. Siscovick, S.M. Schwartz, B.M. Psaty, T.E. Raghunathan, H.L. Vos, A Common Prothrombin Variant (20210 G to A) Increases the Risk of Myocardial Infarction in Young Women Blood. ,vol. 90, pp. 1747- 1750 ,(1997) , 10.1182/BLOOD.V90.5.1747